ROBERT L. PEAKE, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In the article "T3 Euthyroidism in Follicular Thyroid Carcinoma" by Kabadi and Albin (Ann Intern Med 88:359-360, 1978) there is mention in the case history that "the patient was maintained on 75 µg of Cytomel®/day". No dates are given for the administration of triiodothyronine, but it must be clarified that the patient was not receiving this drug when the normal T3 levels were obtained later in the course of her disease.
PEAKE RL. T3 Euthyroidism in Thyroid Carcinoma. Ann Intern Med. ;89:578. doi: 10.7326/0003-4819-89-4-578_2
Download citation file:
Published: Ann Intern Med. 1978;89(4):578.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use